Historical Valuation
LifeStance Health Group Inc (LFST) is now in the Fair zone, suggesting that its current forward PS ratio of 1.72 is considered Fairly compared with the five-year average of -2.90. The fair price of LifeStance Health Group Inc (LFST) is between 3.33 to 18.72 according to relative valuation methord.
Relative Value
Fair Zone
3.33-18.72
Current Price：7.40
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
LifeStance Health Group Inc (LFST) has a current Price-to-Book (P/B) ratio of 1.81. Compared to its 3-year average P/B ratio of 1.72 , the current P/B ratio is approximately 5.48% higher. Relative to its 5-year average P/B ratio of 2.27, the current P/B ratio is about -20.22% higher. LifeStance Health Group Inc (LFST) has a Forward Free Cash Flow (FCF) yield of approximately 4.41%. Compared to its 3-year average FCF yield of 0.71%, the current FCF yield is approximately 518.25% lower. Relative to its 5-year average FCF yield of -0.41% , the current FCF yield is about -1185.63% lower.
P/B
Median3y
1.72
Median5y
2.27
FCF Yield
Median3y
0.71
Median5y
-0.41
Competitors Valuation Multiple
AI Analysis for LFST
The average P/S ratio for LFST competitors is 0.95, providing a benchmark for relative valuation. LifeStance Health Group Inc Corp (LFST.O) exhibits a P/S ratio of 1.72, which is 81.58% above the industry average. Given its robust revenue growth of 16.34%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for LFST
1Y
3Y
5Y
Market capitalization of LFST increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of LFST in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is LFST currently overvalued or undervalued?
LifeStance Health Group Inc (LFST) is now in the Fair zone, suggesting that its current forward PS ratio of 1.72 is considered Fairly compared with the five-year average of -2.90. The fair price of LifeStance Health Group Inc (LFST) is between 3.33 to 18.72 according to relative valuation methord.
What is LifeStance Health Group Inc (LFST) fair value?
LFST's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of LifeStance Health Group Inc (LFST) is between 3.33 to 18.72 according to relative valuation methord.
How does LFST's valuation metrics compare to the industry average?
The average P/S ratio for LFST's competitors is 0.95, providing a benchmark for relative valuation. LifeStance Health Group Inc Corp (LFST) exhibits a P/S ratio of 1.72, which is 81.58% above the industry average. Given its robust revenue growth of 16.34%, this premium appears unsustainable.
What is the current P/B ratio for LifeStance Health Group Inc (LFST) as of Jan 10 2026?
As of Jan 10 2026, LifeStance Health Group Inc (LFST) has a P/B ratio of 1.81. This indicates that the market values LFST at 1.81 times its book value.
What is the current FCF Yield for LifeStance Health Group Inc (LFST) as of Jan 10 2026?
As of Jan 10 2026, LifeStance Health Group Inc (LFST) has a FCF Yield of 4.41%. This means that for every dollar of LifeStance Health Group Inc’s market capitalization, the company generates 4.41 cents in free cash flow.
What is the current Forward P/E ratio for LifeStance Health Group Inc (LFST) as of Jan 10 2026?
As of Jan 10 2026, LifeStance Health Group Inc (LFST) has a Forward P/E ratio of 239.18. This means the market is willing to pay $239.18 for every dollar of LifeStance Health Group Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for LifeStance Health Group Inc (LFST) as of Jan 10 2026?
As of Jan 10 2026, LifeStance Health Group Inc (LFST) has a Forward P/S ratio of 1.72. This means the market is valuing LFST at $1.72 for every dollar of expected revenue over the next 12 months.